COVID: BioNTech to supply new vaccine very soon to neutralise Omicron MD Bureau28 Aug 2022 4:55 PM ISTThe new vaccine is, however, still expected to be more effective in neutralising the variants currently in circulation, the report said.
FDA, EMA found no evidence of causal association between ranitidine and cancer: GSK issues statement Ruchika Sharma13 Aug 2022 12:20 PM ISTNew Delhi: In response to recent speculative commentary regarding U.S. Zantac litigation, GSK plc has issued the following statement regarding Zantac...
EMA starts rolling review of Pfizer-BioNTech variant-adapted COVID vaccine Ruchika Sharma11 Aug 2022 3:45 PM ISTNew Delhi: The European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on...
Novavax COVID shot Nuvaxovid must carry warning of heart inflammation, recommends EU Ruchika Sharma4 Aug 2022 12:59 PM IST"We will work with the relevant regulators to assure our product information is consistent with our common interpretation of the incoming data," U.S....
EU identifies severe allergic reactions as side effects of Novavax COVID vaccine Ruchika Sharma15 July 2022 4:30 PM ISTThe EMA said it would also update the product information for the vaccine to add unusual or decreased feeling in the skin as a new side effect.
Pfizer, BioNTech submit variation to EMA for vaccination of children 6 months to less than 5 years with COMIRNATY Ruchika Sharma11 July 2022 4:27 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the companies have submitted a variation to the European Medicines Agency...
EU regulator begins review of Bavarian Nordic smallpox vaccine Imvanex for monkeypox Ruchika Sharma29 Jun 2022 1:00 PM ISTMost monkeypox patients experience only fever, body aches, chills and fatigue.
Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 12:30 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novartis division Sandoz application for proposed biosimilar Hyrimoz's high concentration formulation accepted by EMA Ruchika Sharma19 Jun 2022 11:30 AM ISTUpon approval, the Hyrimoz (100 mg/mL) citrate-free HCF would offer reduced injection volume and potentially decrease the number of injections...
Sanofi Dupixent wins USFDA nod for atopic dermatitis Ruchika Sharma8 Jun 2022 1:00 PM ISTDupixent is administered as an injection under the skin (subcutaneous injection) at different injection sites.
Oman to fast-track nod of USFDA registered Indian pharma products Ruchika Sharma12 May 2022 10:00 AM IST"We expect that with the fast tracking of registration of Indian pharma products, we can significantly gain in the Omani pharma market which is...
Biocon Biologics Inpremzia gets backing from EMA expert panel Ruchika Sharma2 April 2022 12:43 PM ISTInpremzia is a pre-mixed ready-to-use insulin for IV infusion for patients in hospital and other acute care settings.
